Eleven Biotherapeutics posts $9.7 million net loss in third quarter

Eleven Biotherapeutics reported a net loss of $9.7 million, or $0.50 per share, in the third quarter compared with a net loss of $10.7 million, or $0.66 per share, in the same quarter of 2014, according to a press release. Revenue was reported at $0.1 million in the third quarter compared with $0.5 million in the same quarter of 2014.